SCPS Presents
Psychopharmacology Update 23
Saturday, January 28, 2012
The Olympic Collection
11301 Olympic Blvd.
Los Angeles, CA 90064
310-575-4585
Audio CD/Syllabus Order Form - .pdf
8:15 a.m. - Registration, Continental Breakfast, Booth Exhibits
8:55 a.m - Opening Remarks
9:00 a.m. - Bipolar Spectrum Disorders: Underdiagnosed? Over-diagnosed? Strategies for Treatment -
Mark Rapaport, M.D.,Chair, Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine.
Recent research suggests that clinicians may under diagnose
and improperly treat patients with bipolar spectrum disorders.
We will review the epidemiology, clinical characteristics, and
treatment of bipolar spectrum disorders. Participants will learn
to diagnose bipolar spectrum disorders, develop a treatment
plan for bipolar spectrum disorders, and learn to integrate psychotherapies,
pharmacotherapies, and holistic approaches in
their treatment.
10:00 a.m. - Hormone Replacement Therapy: Helping Your Patient Decide - Deborah Yaeger, M.D., Clinical Professor of Psychiatry and
Biobehavioral Sciences, UCLA Geffen School of Medicine;
Director, Women’s Mental Health Program, VA Greater Los
Angeles Healthcare System.
Significant changes in the risk-benefit calculus of hormone
replacement therapy (HRT) have occurred during the past 10
years. We will review the history of HRT and the ongoing studies
that are redefining the criteria for its use. We will discuss
the role of HRT for depressed women, and how psychiatrists
can educate their patients about HRT’s efficacy and possible
drawbacks.
11:00 a.m. - Break
11:15 a.m. - Consequences of Long Term Treatment With SSRIs: What do we know about safety and side effects? - Thomas Strouse, M.D. - Maddie Katz Professor of Palliative
Care Research and Education; Medical Director, UCLA Resnick
Neurpsychiatric Hospital. Vice-Chair for Clinical Affairs, UCLA
Department of Psychiatry and Biobehavioral Sciences.
The SSRI era began during a time when the relapsing nature of
mood and anxiety disorders was becoming clearer to clinicians
and psychiatric epidemiologists. Many patients subsequently
opted for long-term or open-ended maintenance treatment with
SSRIs based in part on the goal of reducing relapses, but also
in consideration of the relatively superior tolerability of SSRIs
compared to their predecessors. This talk will focus on what
is known about safety , tolerability, and side-effects associated
with long-term therapy with SSRI antidepressants.
12:15 p.m. - Lunch Break (Lunch will not be provided)
1:30 p.m. - Treating Resistant OCD, Compulsive Buying and Skin Picking - Lorrin Koran, M.D.
Professor of Psychiatry, Emeritus, Stanford University Medical Center.
This presentation will present a sequence of data-based treatments
for treatment-resistant OCD, and review the pharmacotherapies
and psychotherapies for two frequently overlooked
impulse control disorders: compulsive buying disorder
and skin picking disorder.
2:30 p.m. - Borderline Personality Disorder: New Findings and Current Controversies - John Oldham, M.D.
Senior Vice President and Chief of Staff
The Menninger Clinic; Professor and Executive Vice Chair
Menninger Department of Psychiatry and Behavioral Sciences
Baylor College of Medicine; President, American Psychiatric
Association.
Overall, there is a reasonable body of evidence that Borderline
Personality Disorder (BPD) as defined in DSM-IV-TR represents
a cohesive class that should be represented as a specific PD
type in DSM-V, in spite of internal heterogeneity and criteria
that represent a hybrid of environment-reactive symptoms and
dimensional traits. Population prevalence of BPD from pooled
data is estimated to be slightly greater than 1%. History of
parental neglect or inconstancy is common, along with considerable
though not invariable early life experience of abuse.
Studies suggest substantial heritability of BPD, and the genetic
and neurobiological contributors to BPD appear prominent in
the serotonin system. Imaging data suggest decreased volume
in limbic and anterior cingulated regions, presumably correlated
with difficulties with impulse control and emotion regulation.
Longitudinally, significant remission rates have been
observed, suggesting that BPD is less “enduring” then previously
believed. Published randomized controlled trials have
demonstrated efficacy of a number of types of psychotherapy
to treat patients with BPD. In this presentation, these areas will
be reviewed in greater detail.
Overview
SCPS is pleased to present a distinguised panel of experts to address topics of practical importance for clinical practice. the program starts with an up to date review of the diangosis and comprehesive treatment of bipolar spectrum disorders. The next presentation clarifies new developments and strategies in the use of HRT, with emphasis on depression in women. We will then learn about the consequences of long term treatment with SSRIs. Following lunch we will consider effective treatment of treament resistant OCD, compulsive buying disorder, and skin picking disorder. The program ends with a special presentation by John Oldham, M.D., President of the American Psychiatric Association, who will provide a broad based update of the treatment of borderlinde personality disorder.
Objectives
At the end of this seminar, participants will have:
$187.00 SCPS Member
$214.00 Non-SCPS Member
$12.00 SCPS Resident *
$22.00 Non-SCPS Resident *
*Must be enrolled in a full-time, degree granting program. Must send photocopy of student I.D. with registration form. NO EXCEPTIONS.
These rates for Registration are available only until 1/24/12.
After this date, and at-door registration: additional $25 per attendee.
Please make check payable to SCPS and mail with this pdf. Registration Form to:
SCPS
2999 Overland Ave., #208
Los Angeles, CA. 90064
You may also pay using Visa, Master Card or Discover. There will be a 5% service fee charged to all credit card payments. If you wish to use a credit card please provide: Name as it appears on the card, Account number, Expiration Date, and Billing Zip Code. Cancellations must be received 48 hours prior to the meeting and will be assessed a $45 administrative processing fee.
SCPS Presents
Technology, Professionalism and Psychiatry
Saturday, October 29, 2011
Thank you to all of our speakers, booth exhibitors and attendees for making this a hugely successful event!
Audio CD's and Syllabus from the meeting are now available. Please click here for Order Form - .pdf
The Southern California Psychiatric Society (SCPS) is accredited by the Institute of Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. SCPS takes responsibility for the content, quality and scientific integrity of this CME activity.
SCPS designates this educational activity for a maximum of 5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
To order cds/tapes from prior events, please contact us at scps2999@earthlink.net
